Follow on Google News
News By Tag
News By Location
Follow on Google News
Clinical trial platform provider encapsia welcomes new COO
By: Scott PR
This approach aligns with encapsia's goal of developing user-friendly, adaptable solutions that have a long-term impact on decentralised clinical trials and data analysis. In turn, life science companies will benefit from the enhanced speed to market and cost-savings. Prioritising data insights to evaluate and select the best-performing techniques mirrors encapsia's commitment to open access integration with expert systems such as randomisation and trial supply management systems. Francis defines data as equalling shared knowledge and information, linking the company commitment to producing real-time data surfaced through user-friendly visualisations.
Commenting on the move, Francis said: "My journey with encapsia begins at a time of technological change, I am looking forward to building on its many strengths in clinical data optimisation. The customer centric ethos fortifies my own approach, which is to create a holistic data management platform with user needs at the core. It's all about looking to the future to see how we can improve our business mindset for the benefits of our customers and the wider industry."
He continues: "There are a lot of companies competing within the technology landscape, and encapsia is uniquely positioned to drive the development of a more accessible, user-experience focused system. Whether the study is decentralised or not, EDC or eSource remains the central technology asset for data entry in a clinical trial. We've completely integrated this into our encapsia platform: a cloud application specifically designed for clinical studies that adapts to the needs of today, and ready for tomorrow. Real-world data (RWD) collection is at the heart of what encapsia does, and I look forward to driving our rapid growth."
Francis is spearheading the 5-year roadmap for encapsia, shifting the focus from solely EDC towards wearables and medical devices, and building on its partnerships with providers of transformative technologies. Encapsia will drive innovation in response to customer needs with the ultimate aim of creating a new platform that supports decentralised, hybrid and traditional clinical trials and encompasses feedback from sponsors and investigators. Its long-term strategic focus is to build an open access, customer centric solution that is dedicated to end users, keeps up with the pace of change in IoT devices and supports new demands as they arise. This will formulate the new clinical trial design and ensure that encapsia and its customers are ready for the future.